PT  - JOURNAL ARTICLE
AU  - Peek, AL
AU  - Rebbeck, TJ
AU  - Leaver, AM
AU  - Puts, NA
AU  - Foster, SL
AU  - Refshauge, KM
AU  - Oeltzschner, G
AU  - ,
TI  - A Comprehensive Guide to MEGA-PRESS for GABA Measurement
AID  - 10.1101/2021.11.24.21266827
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.11.24.21266827
4099  - http://medrxiv.org/content/early/2021/11/26/2021.11.24.21266827.short
4100  - http://medrxiv.org/content/early/2021/11/26/2021.11.24.21266827.full
AB  - Background The aim of this guideline is to provide a series of evidence-based recommendations that allow those new to the field of MEGA-PRESS to produce high-quality data for the measurement of GABA levels using edited magnetic resonance spectroscopy with the MEGA-PRESS sequence at 3T. GABA is the main inhibitory neurotransmitter of the central nervous system and has been increasingly studied due to its relevance in many clinical disorders of the central nervous system. MEGA-PRESS is the most widely used method for quantification of GABA at 3T, but is technically challenging and operates at a low signal-to-noise ratio. Therefore, the acquisition of high-quality MRS data relies on avoiding numerous pitfalls and observing important caveats.Methods The guideline was developed by a working party that consisted of experts in MRS and experts in guideline development and implementation, together with key stakeholders. Strictly following a translational framework, we first identified evidence using a systematically conducted scoping literature review, then synthesised and graded the quality of evidence that formed recommendations. These recommendations were then sent to a panel of 21 world leaders in MRS for feedback and approval using a modified-Delphi process across two rounds.Results The final guideline consists of 23 recommendations across six domains essential for GABA MRS acquisition (Parameters, Practicalities, Data acquisition, Confounders, Quality/reporting, Post-processing). Overall, 78% of recommendations were formed from high-quality evidence, and 91% received agreement from over 80% of the expert panel.Conclusion These 23 expert-reviewed recommendations and accompanying extended documentation form a readily usable guideline to allow those new to the field of MEGA-PRESS to design appropriate MEGA-PRESS study protocols and generate high-quality data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAimie Peek Australian Postgraduate Award and Top-up Scholarship National Health and Medical Research Council (NHMRC) Centre of Research Excellence in recovery following road Traffic Injuries APP1079022; Trudy Rebbeck receives funding from Sydney Research Accelerator (SOAR) Fellowship and NHMRC Career Development Fellowship APP1161467; Georg Oeltzschner receives funding from R00AGO62230Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript https://osf.io/5v9cp/?view_only=b6c70761abdd4d6e9e38d2a7b9944f9f